Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond

dc.contributor.author	Rosina, Mônica Steffen Guise
dc.contributor.author	Shaver, Lea
dc.date.accessioned	2018-05-10T13:36:11Z
dc.date.available	2018-05-10T13:36:11Z
dc.date.issued	2012-08
dc.identifier	http://dx.doi.org/10.1111/j.1748-720X.2012.00658.x
dc.identifier.issn	1048-9843 / 1873-3409
dc.identifier.uri	http://hdl.handle.net/10438/23269
dc.description	Conteúdo online de acesso restrito pelo editor	por
dc.description.abstract	Access to medicines faces a new legal threat: border enforcement of drug patents. Using Brazil as an example, this article shows how the right to health depends on international trade. Border seizures of generic drugs present human rights and trade institutions with a unique challenge. Can public health advocates rise to meet it?	eng
dc.format.extent	p. 197-205
dc.language.iso	eng
dc.publisher	Wiley-Blackwell
dc.relation.ispartofseries	Journal of law medicine & ethics
dc.source	Web of Science
dc.subject	Generic drugs	eng
dc.title	Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond	eng
dc.type	Article (Journal/Review)	eng
dc.subject.area	Ciências sociais	por
dc.subject.bibliodata	Medicamentos genéricos - Regulamentação - Brasil	por
dc.contributor.affiliation	FGV
dc.identifier.doi	10.1111/j.1748-720X.2012.00658.x
dc.rights.accessRights	restrictedAccess	eng
dc.identifier.WoS	000306312100003